Reports Q1 revenue $86.3M, consensus $88.23M. In light of the pending transaction with IKS, TruBridge (TBRG) will not host a conference call or webcast to discuss its first quarter 2026 financial results.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TBRG:
- TruBridge price target raised to $26.25 from $23 at Deutsche Bank
- TruBridge price target raised to $26.25 from $15 at BMO Capital
- TruBridge downgraded to Hold from Buy at Freedom Capital
- TruBridge downgraded to Neutral from Overweight at Cantor Fitzgerald
- TruBridge resumes, up 12% after IKS Health takeover agreement